Hims & Hers Stock Analysis: The $6.5B 2030 Opportunity? #healthtech #HIMSstock
1 extracted signal · 0 resolved · 1 still active
TRADING NEWSIndependent analyst profile- Source published
- 12 Oct 2026, 11:30 UTC
- Recorded by Tahlil Plus
- 12 Oct 2026, 11:33 UTC

AI-generated source summary
The analysis focuses on HIMS stock, presenting its financial performance and growth trajectory. The company's revenue grew significantly from $250 million in 2020 to an projected $6.5 billion by 2030, with a 12-month revenue forecast of $2.6 billion. Key performance indicators show substantial growth in recent years, with a projected increase in revenue by 2025. The company's operational efficiency is highlighted by its increasing profit margins, which rose from -8.44% in 2021 to 8.75% in 2025. However, the analysis also points to potential risks, such as fluctuating operating margins and a high beta of 2.4, indicating significant volatility relative to the broader market. The current valuation is estimated at $27.50 per share, with analyst price targets ranging from $26.00 to $42.00, averaging $32.82. Analysts recommend a 'Hold' for the stock, suggesting a neutral short-to-medium term outlook.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
TRADING NEWS
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
